In this Pharma Matters Q&A, Anshul Gupte of PCI Pharma Services discusses investments and opportunities in sterile ...
Kytopen Corp., a leader in non-viral, continuous flow cellular engineering technologies, T-CURX GmbH ("T-CURX"), a leader in transposon-based CAR-T manufacturing, and Fraunhofer IZI, a developer of ...
Emergent BioSolutions Inc. (NYSE: EBS) today announced a multi-year agreement with SAB Biotherapeutics, Inc. (Nasdaq: SABS, SAB BIO) to support the process development and manufacturing of SAB-142, ...
As the global biopharmaceutical industry undergoes rapid restructuring, two powerful forces-policy evolution and supply chain ...
Emergent BioSolutions Inc. (NYSE: EBS) today announced a multi-year agreement with SAB Biotherapeutics, Inc. (NASDAQ: SABS) to support the process development and manufacturing of SAB-142, SAB BIO’s ...
The rapid evolution of cell and gene therapy (CGT) is driving unprecedented innovation in manufacturing, yet the adoption of ...
Inc. (NYSE: EBS) today announced a multi-year agreement with SAB Biotherapeutics, Inc. (Nasdaq: SABS, SAB BIO) to support the process ...
Aesthetic medical product developer BNCERA opened its first manufacturing plant in Korea in Incheon Tuesday, accelerating its ...
Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for POHERDY ® (pertuzumab) 420 mg/14 mL injection for ...
Robinson Pharma Inc., a leading USA-based contract manufacturer of dietary supplements, today highlighted key trends shaping the nutraceutical manufacturing industry in 2026, as global demand for ...
New York, United States, April 29, 2026 /MarketersMEDIA/ -- Amerigo Scientific, a trusted provider of critical reagents and assay solutions for life science research, released its expanded portfolio ...
Bildnachweis: Siegfried. DINAMIQS, a Siegfried company (SIX: SFZN), today announced that it has received the manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results